BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FES, FPS, 2242, ENSG00000182511, P07332
120 results:

  • 1. Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression.
    Vu L; Garcia-Mansfield K; Pompeiano A; An J; David-Dirgo V; Sharma R; Venugopal V; Halait H; Marcucci G; Kuo YH; Uechi L; Rockne RC; Pirrotte P; Bowser R
    Ann Clin Transl Neurol; 2023 Nov; 10(11):2025-2042. PubMed ID: 37646115
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
    Gan Y; Liu T; Feng W; Wang L; Li LI; Ning Y
    Oncol Res; 2023; 31(3):333-343. PubMed ID: 37305383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.
    Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W
    Front Immunol; 2022; 13():962000. PubMed ID: 36275721
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SRRM2 organizes splicing condensates to regulate alternative splicing.
    Xu S; Lai SK; Sim DY; Ang WSL; Li HY; Roca X
    Nucleic Acids Res; 2022 Aug; 50(15):8599-8614. PubMed ID: 35929045
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ISCA2 deficiency leads to heme synthesis defects and impaired erythroid differentiation in K562 cells by indirect ROS-mediated IRP1 activation.
    Wang J; Jiang M; Yue G; Zhu L; Wang X; Liang M; Wu X; Li B; Pang Y; Tan G; Li J
    Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119307. PubMed ID: 35714932
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
    Cernan M; Szotkowski T; Hubacek J; Kolar M; Faber E; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):236-245. PubMed ID: 35258041
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cancer incidence among the NATO peacekeeping forces in Bosnia and Kosovo: a systematic review and metanalysis.
    Cocco P
    Med Lav; 2022 Feb; 113(1):e2022011. PubMed ID: 35226651
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
    Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
    Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.
    Chen BR; Deshpande A; Barbosa K; Kleppe M; Lei X; Yeddula N; Vela PS; Campos AR; Wechsler-Reya RJ; Bagchi A; Meshinchi S; Eaves C; Jeremias I; Haferlach T; Frank DA; Ronai Z; Chanda S; Armstrong SA; Adams PD; Levine RL; Deshpande AJ
    Blood; 2021 Jun; 137(24):3403-3415. PubMed ID: 33690798
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis.
    Goetzl EJ; Srihari VH; Guloksuz S; Ferrara M; Tek C; Heninger GR
    Transl Psychiatry; 2020 Oct; 10(1):361. PubMed ID: 33106473
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.
    Chen WL; Li DD; Chen X; Wang YZ; Xu JJ; Jiang ZY; You QD; Guo XK
    Eur J Med Chem; 2020 Feb; 188():112027. PubMed ID: 31923859
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged leukemia.
    Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ
    Cells; 2019 Oct; 8(11):. PubMed ID: 31717699
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins.
    Klesmith JR; Su L; Wu L; Schrack IA; Dufort FJ; Birt A; Ambrose C; Hackel BJ; Lobb RR; Rennert PD
    Mol Pharm; 2019 Aug; 16(8):3544-3558. PubMed ID: 31242389
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Novel sub-cellular localizations and intra-molecular interactions may define new functions of Mixed Lineage leukemia protein.
    Karole AM; Chodisetty S; Ali A; Kumari N; Tyagi S
    Cell Cycle; 2018; 17(24):2684-2696. PubMed ID: 30489191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo.
    Weir MC; Shu ST; Patel RK; Hellwig S; Chen L; Tan L; Gray NS; Smithgall TE
    ACS Chem Biol; 2018 Jun; 13(6):1551-1559. PubMed ID: 29763550
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.
    Siveen KS; Prabhu KS; Achkar IW; Kuttikrishnan S; Shyam S; Khan AQ; Merhi M; Dermime S; Uddin S
    Mol Cancer; 2018 Feb; 17(1):31. PubMed ID: 29455667
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
    Di Blasi R; Cattaneo C; Lewis RE; Tumbarello M; Angelici L; Dragonetti G; Busca A; Cambò B; Candoni A; Cesarini M; Cesaro S; Delia M; Fanci R; Farina F; Garzia M; Giordano A; Martino B; Melillo L; Nadali G; Perriello V; Picardi M; Quinto AM; Salutari P; Spolzino A; Vacca A; Vetro C; Zancanella M; Nosari A; Aversa F; Pagano L;
    Ann Hematol; 2018 May; 97(5):791-798. PubMed ID: 29411126
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting protein-protein interaction between MLL1 and reciprocal proteins for leukemia therapy.
    Wang ZH; Li DD; Chen WL; You QD; Guo XK
    Bioorg Med Chem; 2018 Jan; 26(2):356-365. PubMed ID: 29254892
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dual inhibition of fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
    Weir MC; Hellwig S; Tan L; Liu Y; Gray NS; Smithgall TE
    PLoS One; 2017; 12(7):e0181178. PubMed ID: 28727840
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.